Publications
5 shownPhase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
Purpose Both gemcitabine (GEM) and fluoropyrimidines are valuable treatment for advanced pancreatic cancer. This open-label study was designed to compare the overall survival (O...
Frequent Co-Authors
Researcher Info
- h-index
- 5
- Publications
- 6
- Citations
- 5,085
- Institution
- Cancer Research UK
External Links
Identifiers
- ORCID
- 0000-0002-6201-7399
Impact Metrics
h-index
5
h-index: Number of publications with at least h citations each.